Vrna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vrna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vrna Today - Breaking & Trending Today

China Universal Asset Management Co. Ltd. Trims Stake in Verona Pharma plc (NASDAQ:VRNA)

China Universal Asset Management Co. Ltd. cut its holdings in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 73.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 14,878 shares of the company’s stock after selling 40,806 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Verona Pharma were worth […] ....

New Zealand General , New Zealand , United States , Verona Pharma , Kennedy Capital Management , China Universal Asset Management Co , American Century Companies Inc , Wellington Management Group , Holdings Channel , Legato Capital Management , China Universal Asset Management , Free Report , Universal Asset Management , Capital Management , Management Group , Century Companies , Get Free Report , Visit Holdingschannel , Verona Pharma Daily , Nasdaq Vrna , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

China Universal Asset Management Co. Ltd. Has $296,000 Position in Verona Pharma plc (NASDAQ:VRNA)

China Universal Asset Management Co. Ltd. lessened its stake in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 73.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 14,878 shares of the company’s stock after selling 40,806 shares during the quarter. China Universal […] ....

Verona Pharma , China Universal Asset Management Co , Hermes Inc , Eventide Asset Management , Citigroup Inc , Schonfeld Strategic Advisors , China Universal Asset Management , Free Report , Universal Asset Management , Asset Management , Street Corp , Strategic Advisors , Get Free Report , Verona Pharma Daily , Nasdaq Vrna , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Verona Pharma (NASDAQ:VRNA) Shares Up 4.9%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price shot up 4.9% on Thursday . The stock traded as high as $17.15 and last traded at $17.02. 285,724 shares were traded during trading, a decline of 43% from the average session volume of 502,863 shares. The stock had previously closed at $16.23. Analyst Ratings […] ....

Verona Pharma , Tower Research Capital , Cape Investment Advisory Inc , Goldman Sachs Group Inc , Get Free Report , Investment Advisory , Financial Markets , Sachs Group , Research Capital , Verona Pharma Daily , Nasdaq Vrna ,

Verona Pharma (NASDAQ:VRNA) Earns Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $32.00 price objective on the stock. Separately, Wedbush reiterated an outperform rating and issued a $33.00 target price on shares of Verona Pharma in a research report on […] ....

Kathleena Rickard , Martin Edwards , Verona Pharma , Schonfeld Strategic Advisors , Hermes Inc , Citigroup Inc , Securities Exchange Commission , Eventide Asset Management , Free Report , Get Free Report , Exchange Commission , Director Martin Edwards , Asset Management , Street Corp , Strategic Advisors , Verona Pharma Daily , Nasdaq Vrna , Reiterated Rating , Hc Wainwright ,

Verona Pharma (NASDAQ:VRNA) Stock Price Down 8.9%

Verona Pharma plc (NASDAQ:VRNA – Get Free Report) shares were down 8.9% on Tuesday . The stock traded as low as $17.36 and last traded at $18.43. Approximately 160,862 shares changed hands during trading, a decline of 74% from the average daily volume of 609,346 shares. The stock had previously closed at $20.24. Analyst Upgrades […] ....

Davidr Ebsworth , Verona Pharma , Martin Edwards , Goldman Sachs Group Inc , Verona Pharma Company Profile , Citigroup Inc , Cubist Systematic Strategies , Envestnet Asset Management Inc , Renaissance Technologies , Get Free Report , Pharma Stock Down , Director David , Director Martin Edwards , Sachs Group , Asset Management , Verona Pharma Daily , Nasdaq Vrna ,